Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 2/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7310043 | 0.93 | EBP (0.33) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7304455 | 0.93 | EBP (0.33) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7310937 | 0.91 | CACNA1B (0.33) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7304766 | 0.91 | EBP (0.35) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7308400 | 0.90 | EBP (0.32) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7304227 | 0.90 | CACNA1B (0.33) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7304263 | 0.88 | EBP (0.34) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7313956 | 0.88 | CACNA1B (0.32) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7315131 | 0.88 | EBP (0.36) | EBPSIGMAR1CACNA1B | |
| SCHEMBL7319052 | 0.88 | EBP (0.35) | EBPSIGMAR1CACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1041064-A2 | N-substituted alpha aminoacid amides as calcium channel modulators | ELI LILLY AND COMPANY LIMITED (GB) | 2000-10-04 | — | — | EP | disclosed |
| EP-0805147-A1 | Novel N-substituted alpha aminoacid amides as calcium channel modulators | LILLY INDUSTRIES LIMITED (GB) | 1997-11-05 | — | — | EP | disclosed |